In conclusion, these observations indicated that CD10 and Tfh markers highlighted the source of origin of this tumor cell which resides among non-neoplastic reactive T cells (CD4+ and CD8+) in the TME of AITL (144, 157, 160). The gene discussed is CD8A; the disease is neoplasm.